Ticker

All-share deal to acquire a 100% interest in Forester WHITE ROCK, BC / ACCESS Newswire / February 26, 2026 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena" or the "Company") is pleased to announce the proposed acquisition of a 100% interest in the Forester Gold Project ("Forester" or the "Project"), located along-trend of Orla Mining's Musselwhite Gold Mine in northwestern Ontario. Highlights 100%…

BML Capital Management LLC lessened its position in shares of Athira Pharma, Inc. (NASDAQ: ATHA) by 90.0% in the third quarter, according to its most recent filing with the SEC. The firm owned 323,066 shares of the company's stock after selling 2,907,601 shares during the quarter. Athira Pharma makes up approximately 1.0% of

Athira Pharma (NASDAQ: ATHA - Get Free Report) and Alterity Therapeutics (NASDAQ: ATHE - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership. Risk and Volatility Athira Pharma has a

HIGHLIGHTS On February 5th , 2026, the Company completed two financings totaling CAD ~$63M ( See News Release ), including a strategic investment by Queens Road Capital; The quantum and strong institutional support of the combined financings is recognition of the highly impactful results and project de-risking achieved during the 2025 Angilak Exploration Program; ATHA is now one of the best capitalized uranium…

Hong Kong, Hong Kong--(Newsfile Corp. - February 5, 2026) - Queen's Road Capital Investment Ltd. (TSX: QRC) (the "Company" or "QRC") announces that on February 5, 2026, it acquired a convertible debenture of ATHA Energy Corp. ("ATHA") in the principal amount of US$25,000,000 (approximately Can.